Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Anhui Medical UniversityNo recent work listed

Congjun Zhang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0009-0000-1005-5812; OpenAlex author ID A5066875591. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2021: 2 papers · 2022: 1 paper

Papers 3

  1. Anlotinib plus nab-paclitaxel/gemcitabine as first-line treatment prolongs survival in patients with unresectable or metastatic pancreatic adenocarcinoma: a re… Last author DOI 10.21037/atm-22-544↗
  2. Tumor Microenvironment Characteristics of Pancreatic Cancer to Determine Prognosis and Immune-Related Gene Signatures. Co-author DOI 10.3389/fmolb.2021.645024↗
  3. m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.3389/fonc.2021.696371↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Hongyang Wu · 1 shared paper, 2022 · strength 0.16
  2. Wei Huang · 1 shared paper, 2022 · strength 0.16
  3. Xiao Xu · 1 shared paper, 2021 · strength 0.14
  4. Shengyang Chen · 1 shared paper, 2021 · strength 0.14
  5. Yuqiang Li · 1 shared paper, 2021 · strength 0.14

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.